0000944809-21-000023.txt : 20210317 0000944809-21-000023.hdr.sgml : 20210317 20210317160912 ACCESSION NUMBER: 0000944809-21-000023 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210312 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPKO HEALTH, INC. CENTRAL INDEX KEY: 0000944809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752402409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33528 FILM NUMBER: 21750636 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD. CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 305-575-4181 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD. CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: Opko Health, Inc. DATE OF NAME CHANGE: 20070621 FORMER COMPANY: FORMER CONFORMED NAME: eXegenics Inc DATE OF NAME CHANGE: 20040505 FORMER COMPANY: FORMER CONFORMED NAME: EXEGENICS INC DATE OF NAME CHANGE: 20011114 8-K 1 opk-20210312.htm 8-K opk-20210312
0000944809false00009448092021-03-122021-03-12



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 12, 2021
OPKO Health, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware001-3352875-2402409
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
4400 Biscayne Blvd.Miami,Florida33137
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: (305575-4100
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareOPKNASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company        
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.        ☐



ITEM 1.01.
Entry into a Material Definitive Agreement.
On March 12, 2021, a wholly owned subsidiary of OPKO Health, Inc. (the “Company”), Bio-Reference Laboratories, Inc., a New Jersey corporation (“BRLI”), and certain of its subsidiaries entered into an amendment (the “Amendment”) to that certain Credit Agreement dated as of November 5, 2015 (as amended, the “Credit Agreement”), by and among BRLI, certain of its subsidiaries from time to time party thereto, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent for the lenders. Pursuant to the Amendment, letters of credit, including renewals and extensions, may extend past the maturity date for the Credit Agreement, which is November 5, 2021, subject to certain conditions, including the posting of cash collateral. The Amendment additionally incorporates certain new electronic signature requirements applicable to the Credit Agreement. Except as described in this Current Report on Form 8-K, the other terms of the Credit Agreement remain unchanged.
The foregoing descriptions of the Credit Agreement and the Amendment are only summaries and are qualified in their entirety by references to the complete text of the Credit Agreement and the Amendment. A copy of the Credit Agreement was filed with the Company’s Annual Report on Form 10-K as Exhibit 10.23, filed with the Securities and Exchange Commission on February 29, 2016, and incorporated herein by reference. A copy of the Amendment is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated herein by reference.
ITEM 9.01.
Financial Statements and Exhibits.
(d)Exhibits
Exhibit No.Description
10.1Amendment No. 12 to Credit Agreement, dated as of March 12, 2021, by and among BioReference Laboratories, Inc., certain of its subsidiaries, and JPMorgan Chase Bank, N.A.
104Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document





Exhibit Index




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OPKO Health, Inc.
By:
/s/ Steven D. Rubin
Date: March 17, 2021
Name:
Steven D. Rubin
Title:
Executive Vice President - Administration


EX-10.1 2 ex101jpmamend3-12x21.htm EX-10.1 Document


EXECUTION VERSION
AMENDMENT NO. 12 TO CREDIT AGREEMENT
AMENDMENT NO. 12 TO CREDIT AGREEMENT (this “Amendment”), dated as of March 12, 2021, is entered into among BIO-REFERENCE LABORATORIES, INC., a New Jersey corporation (“Company”), the Subsidiary Borrowers party hereto (“Subsidiary Borrowers,” and together with Company, each a “Borrower” and, collectively, the “Borrowers”), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as the administrative agent for the Lenders (the “Administrative Agent”).

W I T N E S S E T H :
WHEREAS, the Borrowers, the other Loan Parties party thereto, the Lenders party thereto, and the Administrative Agent have executed and delivered that certain Credit Agreement dated as of November 5, 2015, as amended by Amendment No. 1 to Credit Agreement dated as of February 29, 2016, as amended by Amendment No. 2 to Credit Agreement dated as of September 26, 2016, as amended by Amendment No. 3 to Credit Agreement dated as of March 17, 2017, as amended by Amendment No. 4 to Credit Agreement dated as of August 7, 2017, as amended by Amendment No. 5 to Credit Agreement dated as of November 8, 2017, as amended by Amendment No. 6 to Credit Agreement dated as of December 22, 2017, as amended by Waiver Under and Amendment No. 7 to Credit Agreement dated as of February 28, 2018, as amended by Amendment No. 8 to Credit Agreement dated as of February 26, 2019, as amended by Amendment No. 9 to Credit Agreement dated as of August 6, 2019, as amended by Amendment No. 10 to Credit Agreement dated as of November 4, 2019, and as amended by Amendment No. 11 to Credit Agreement dated as of February 25, 2020 (as further amended, restated, supplemented, or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”); and

WHEREAS, the Borrowers have requested that the Lenders and the Administrative Agent make certain amendments to the Credit Agreement, and the Lenders party hereto, constituting all Lenders under the Credit Agreement, have agreed to such amendments, subject to the terms and conditions hereof.

NOW, THEREFORE, for and in consideration of the above premises and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the parties hereto, each of the Borrowers, the other Loan Parties, the Lenders and the Administrative Agent hereby covenant and agree as follows:

SECTION 1. Definitions. Unless otherwise specifically defined herein, each term used herein (and in the recitals above) which is defined in the Credit Agreement shall have the meaning assigned to such term in the Credit Agreement. As of the date hereof, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of like import, and each reference in the other Loan Documents to the Credit Agreement (including, without limitation, by means of words like “thereunder,” “thereof” and words of like import), shall mean and be a reference to the Credit Agreement, as amended hereby.
NAI-1515894028v5    


SECTION 2. Amendments to Credit Agreement. Effective upon the satisfaction of the conditions precedent set forth in Section 3, the Credit Agreement is hereby amended as follows:
(a) Section 1.01 of the Credit Agreement is hereby amended by adding the following definitions in the appropriate alphabetical order:
    “Amendment No. 12 Effective Date” means March 12, 2021.
Columbia Casualty Letter of Credit” means that certain Letter of Credit issued by the Issuing Bank in the amount of $1,200,000 for the benefit of Columbia Casualty Company.
Electronic Signature” means an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.
(b) Section 2.06(c) of the Credit Agreement is hereby amended so it reads, in its entirety, as follows:
    (c)    Expiration Date. Each Letter of Credit shall expire (or be subject to termination or non-renewal by notice from the Issuing Bank to the beneficiary thereof) at or prior to the close of business on the earlier of (i) the date one year after the date of the issuance of such Letter of Credit (or, in the case of any renewal or extension thereof, including, without limitation, any automatic renewal provision, one year after such renewal or extension) and (ii) the date that is five Business Days prior to the Maturity Date; provided, however, such limitation shall not apply if cash collateral in an amount equal to 103% of the portion of the LC Exposure attributable to such Letter of Credit as of such date plus accrued and unpaid interest thereon has been deposited in an account acceptable to the Administrative Agent; provided, further, that with respect to the Columbia Casualty Letter of Credit, such limitation shall not apply if such cash collateral is provided in a manner acceptable to the Administrative Agent within 30 days of the Amendment No. 12 Effective Date.
(c) Section 9.06(b) of the Credit Agreement is hereby amended so it reads, in its entirety, as follows:
(b)    Delivery of an executed counterpart of a signature page of (x) this Agreement, (y) any other Loan Document and/or (z) any document, amendment, approval, consent, information, notice (including, for the avoidance of doubt, any notice delivered pursuant to Section 9.01), certificate, request, statement, disclosure or authorization related to this Agreement, any other Loan Document and/or the transactions contemplated hereby and/or thereby (each an “Ancillary Document”) that is an Electronic Signature transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page shall be effective as delivery of a manually executed counterpart of this Agreement, such other Loan Document or such Ancillary Document, as applicable. The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to this Agreement, any other Loan Document and/or any Ancillary Document shall be deemed to include Electronic Signatures, deliveries or the keeping of records in any electronic form (including deliveries by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page), each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be; provided that nothing herein shall require the Administrative Agent to accept Electronic Signatures in any form or format without its prior written consent and pursuant to procedures approved by it; provided, further, without limiting the foregoing, (i) to the extent the
NAI-1515894028v5    2


Administrative Agent has agreed to accept any Electronic Signature, the Administrative Agent and each of the Lenders shall be entitled to rely on such Electronic Signature purportedly given by or on behalf of the Borrowers or any other Loan Party without further verification thereof and without any obligation to review the appearance or form of any such Electronic signature and (ii) upon the request of the Administrative Agent or any Lender, any Electronic Signature shall be promptly followed by a manually executed counterpart. Without limiting the generality of the foregoing, the Borrowers and each other Loan Party hereby (i) agrees that, for all purposes, including without limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the Administrative Agent, the Lenders, the Borrowers and the other Loan Parties, Electronic Signatures transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page and/or any electronic images of this Agreement, any other Loan Document and/or any Ancillary Document shall have the same legal effect, validity and enforceability as any paper original, (ii) the Administrative Agent and each of the Lenders may, at its option, create one or more copies of this Agreement, any other Loan Document and/or any Ancillary Document in the form of an imaged electronic record in any format, which shall be deemed created in the ordinary course of such Person’s business, and destroy the original paper document (and all such electronic records shall be considered an original for all purposes and shall have the same legal effect, validity and enforceability as a paper record), (iii) waives any argument, defense or right to contest the legal effect, validity or enforceability of this Agreement, any other Loan Document and/or any Ancillary Document based solely on the lack of paper original copies of this Agreement, such other Loan Document and/or such Ancillary Document, respectively, including with respect to any signature pages thereto and (iv) waives any claim against any Indemnitee for any Liabilities arising solely from the Administrative Agent’s and/or any Lender’s reliance on or use of Electronic Signatures and/or transmissions by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page, including any Liabilities arising as a result of the failure of the Borrowers and/or each Loan Party to use any available security measures in connection with the execution, delivery or transmission of any Electronic Signature.
SECTION 3. Conditions Precedent. This Amendment shall become effective on the date the following conditions precedent shall have been satisfied:
(a) receipt by the Administrative Agent of signatures to this Amendment from the parties listed on the signature pages hereto; and
(b) the Administrative Agent shall have received from the Borrowers (or the Administrative Agent shall be satisfied with arrangements made for the payment thereof) all other costs, fees, and expenses owed by the Borrowers to the Administrative Agent in connection with this Amendment, including, without limitation, reasonable attorneys’ fees and expenses, in accordance with Section 9.03 of the Credit Agreement
SECTION 4. Miscellaneous.
(a) Representations and Warranties. To induce the Administrative Agent and Lenders to enter into this Amendment, the Borrowers hereby represent and warrant to the Administrative Agent and the Lenders that all representations and warranties of the Borrowers contained in Article III of the Credit Agreement or any other Loan Document are true and correct in all material respects with the same effect as though made on and as of the date hereof (except with respect to representations and warranties made as of an expressed date, which representations and warranties are true and correct in all material respects as of such date).
NAI-1515894028v5    3


(b) No Offset. To induce the Administrative Agent and Lenders to enter into this Amendment, the Borrowers hereby acknowledge and agree that, as of the date hereof, and after giving effect to the terms hereof, there exists no right of offset, defense, counterclaim, claim, or objection in favor of the Borrowers or arising out of or with respect to any of the loans or other obligations of the Borrowers owed by the Borrowers under the Credit Agreement or any other Loan Document. No Offset. To induce the Administrative Agent and Lenders to enter into this Amendment, the Borrowers hereby acknowledge and agree that, as of the date hereof, and after giving effect to the terms hereof, there exists no right of offset, defense, counterclaim, claim, or objection in favor of the Borrowers or arising out of or with respect to any of the loans or other obligations of the Borrowers owed by the Borrowers under the Credit Agreement or any other Loan Document.
(c) Loan Document. The parties hereto hereby acknowledge and agree that this Amendment is a Loan Document.
(d) Effect of Amendment. Except as set forth expressly herein, all terms of the Credit Agreement and the other Loan Documents shall be and remain in full force and effect, and shall constitute the legal, valid, binding, and enforceable obligations of the Borrowers, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.
(e) No Novation or Mutual Departure. The Borrowers expressly acknowledge and agree that (i) this Amendment does not constitute or establish, a novation with respect to the Credit Agreement or any of the other Loan Documents, or a mutual departure from the strict terms, provisions, and conditions thereof, other than with respect to the amendments set forth in Section 2 above, and (ii) nothing in this Amendment shall affect or limit the Administrative Agent’s or any Lender’s right to (x) demand payment of the Obligations under, or demand strict performance of the terms, provisions and conditions of, the Credit Agreement and the other Loan Documents (in each case, as amended), as applicable, (y) exercise any and all rights, powers, and remedies under the Credit Agreement or the other Loan Documents (in each case, as amended hereby) or at law or in equity, or (z) do any and all of the foregoing, immediately at any time during the occurrence of an Event of Default and in each case, in accordance with the terms and provisions of the Credit Agreement and the other Loan Documents (in each case, as amended hereby).
(f) Counterparts. This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed to be an original and all of which counterparts, taken together, shall constitute but one and the same instrument. This Amendment may be executed by each party on separate copies, which copies, when combined so as to include the signatures of all parties, shall constitute a single counterpart of this Amendment.
(g) Fax or Other Transmission. Delivery by one or more parties hereto of an executed counterpart of this Amendment via facsimile, telecopy, or other electronic method of transmission pursuant to which the signature of such party can be seen (including, without
NAI-1515894028v5    4


limitation, Adobe Corporation’s Portable Document Format) shall have the same force and effect as the delivery of an original executed counterpart of this Amendment. Any party delivering an executed counterpart of this Amendment by facsimile or other electronic method of transmission shall also deliver an original executed counterpart, but the failure to do so shall not affect the validity, enforceability, or binding effect of this Amendment.
(h) Recitals Incorporated Herein. The preamble and the recitals to this Amendment are hereby incorporated herein by this reference.
(i) Section References. Section titles and references used in this Amendment shall be without substantive meaning or content of any kind whatsoever and are not a part of the agreements among the parties hereto evidenced hereby.
(j) Governing Law. This Amendment shall be governed by and construed in accordance with the internal laws (and not the law of conflicts) of the State of New York, but giving effect to federal laws applicable to national banks.
(k) Severability. Any provision of this Amendment which is prohibited or unenforceable shall be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof in that jurisdiction or affecting the validity or enforceability of such provision in any other jurisdiction.
(l) Reaffirmation of Loan Parties. Each Loan Party (i) consents to the execution and delivery of this Amendment, (ii) reaffirms all of its obligations and covenants under the Loan Documents (including, without limitation, the Collateral Documents and the Loan Guaranty) to which it is a party, and (iii) agrees that, except to the extent amended hereby, none of its respective obligations and covenants under the Loan Documents shall be reduced or limited by the execution and delivery of this Amendment.
[SIGNATURES ON FOLLOWING PAGES.]
NAI-1515894028v5    5


    IN WITNESS WHEREOF, the Borrowers, the other Loan Parties, the Administrative Agent and the Lenders have caused this Amendment to be duly executed by their respective duly authorized officers as of the day and year first above written.
BORROWERS:

BIO-REFERENCE LABORATORIES, INC.
GENEDX, INC.
FLORIDA CLINICAL LABORATORY, INC.
MERIDIAN CLINICAL LABORATORY CORP.


By: /s/ Adam Logal    
    Name: Adam Logal
    Title: Director, Vice President


OTHER LOAN PARTIES:

CAREEVOLVE.COM, INC.
BRLI-GENPATH DIAGNOSTICS, INC.
GENEDX MENA LLC


By: /s/ Adam Logal    
    Name: Adam Logal
    Title: Director, Vice President & Treasurer



NAI-1515894028v5     [BRLI – Amendment No. 12 to Credit Agreement]



JPMORGAN CHASE BANK, N.A.,
individually as a Lender and as Administrative Agent, Issuing Bank and Swingline Lender


By: /s/ Helen D. Davis            
    Name:    Helen D. Davis
    Title:    Authorized Officer


[BRLI – Amendment No. 12 to Credit Agreement]
EX-101.SCH 3 opk-20210312.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - COVER PAGE COVER PAGE link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 opk-20210312_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 opk-20210312_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 opk-20210312_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover [Abstract] Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 opk-20210312_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 opk-20210312_htm.xml IDEA: XBRL DOCUMENT 0000944809 2021-03-12 2021-03-12 0000944809 false 8-K 2021-03-12 OPKO Health, Inc. DE 001-33528 75-2402409 4400 Biscayne Blvd. Miami, FL 33137 305 575-4100 false false false false Common Stock, par value $0.01 per share OPK NASDAQ false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.20.4
COVER PAGE COVER PAGE
Mar. 12, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Mar. 12, 2021
Entity Registrant Name OPKO Health, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-33528
Entity Tax Identification Number 75-2402409
Entity Address, Address Line One 4400 Biscayne Blvd.
Entity Address, City or Town Miami,
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33137
City Area Code 305
Local Phone Number 575-4100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol OPK
Security Exchange Name NASDAQ
Entity Central Index Key 0000944809
Amendment Flag false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( "6!<5('04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " E@7%2GR"J"^\ K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$Z@8R;-I:.G#@8K;.QF;+4UBQUC:R1]^SE9FS*V!QCX8NGW MIT_@1@>I^XC/L0\8R6*Z&UWGD]1AS4Y$00(D?4*G4ID3/C(2C] MH8X(%>8WZ5K*1SP#6[3GZM-X_[+6LK7HF"UX6XWXN5Y _YO$^N/_QNPJXW]F#_ ML?%5L&W@U[]HOP!02P,$% @ )8%Q4IE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" E@7%27^ V33,$ Y$ & 'AL+W=OBS0>AT!%%HI3.5/UB2W=&VM5>F,00JXF=L9T" M_WZ/ R2,)IS0JFIL8K\\/O9Y;7>PDNI-QXP9LDX3H:]:L3'99\?18^&DE(O6<%!\-E7#@:W]!R]\&1O[@3,<9'3)9LS\G4T5U)Q2)>(I$YI+011;7+5&WN=K M/[ =BA;?.%OI@S*Q0YE+^68K=]%5R[5$+&&AL1(4'N]LS)+$*@''CYUHJ_Q. MV_&PO%>_+08/@YE3S<8R^FN,Q"D7&R?=+T+Q&$']T@'?]?!+[BW7U10WE!#AP,E5T39UJ!F M"\50B]X QX6=E9E1\)9#/S, MR#"'Y63(ZR9C=2/$N_?/[A&(H(0(3H.8,L5E1"8B(C!OM3RXTC[BOWWZU!#S M;LG6114GPG"S(2]LR6W4 ?*)IK5DN,[S]/Z9?&4T,7&;W(GP'&&[*-DN3F$# M-:DRJ:C-Z#:9&0@=D8J,92Z,VL SJ@7&Q6\F"&&O).R=0GC+$T:>\G3.5!T( MKN&ZWEFGT_7["$^_Y.F?PO-*U^0N@A7'%SPLPH;0X8J][ID?N/![B>!=EGB7 MI^"-HD@QK=O[ GF =N19U,XBKA@$KDNNN0[I!B2ND_<(6WB>6QFD^R'2L:W! MFGN5*U%KE+C<(ZIDN]IX>Q5?N ASMY,8$C.,(<1\$%.FX7 ZGV @^W\ <90DRF ML128932(="$M \]U,:)J!_!PZ_ZNN#%,0-!<[P]"U5+C0@B::84B5\7NX M.<]DPD-NN%B21UC>BM.DE@=7:>2I;-[#/7JJV%D(X6&07]OC!!,1G%6>%XLC M\X?K-9)5AN_A_OP+V9W6.9 U N*RC8"5Y7LG>?XD96IIY_,+*)C8+K:,BDTM M&B[8A.97)N_CKOS*#>S;<@$GJC_F?Y(9"W-(A5JF!B6;.K#)SHP,W]HDHXJ\ MTR1GY'?WW/5(!A.A8ZI0ZFH#\'&S?E4TLH&<;=*YK$V+!@$XJF$@!Z=UW)SW M\2*3=1A3L61'CXX-0D^CV^!:ZOM/75;,3(K[H9S:>"F611CN-LS91O ^X649E^QU\WROP7#_P%02P,$ M% @ )8%Q4H.II0/4 0 ,@8 T !X;"]S='EL97,N>&ULU57;BM1 M$/V5IC_ GD1V04D"*BP(*@L[#[YVDDK2T#<[E3'9K[<[G=NX#*@/HB^3.J>J M3YV^3M;C).&I T R*JG[G':(]BUC?=6!XOTK8T'[3&.5&;0F-,39476&+TSKVDD?"E70"Y.;E,;5X+8V"5VI(I/0 M!#M.M%WXHK$L)!&-\D$M><GSVL(Y; RU8@Y5/8PJ_-E?;8D+@7'^NP#21, M=0V]H26,,A$$_:-:U#[(WOV1++'B8O#]X&>C9_QM, B/#AHQSGALMOZWU)/; MZMQ:.;V3HM4*XMQ_N6&1\74PQ6]NJ ;2\)#F-,OX7V5NP=2 M#D*BT OJ1%V#?G%/O3SRTC_@5_J^OH:&#Q+/6S*G>_P9:C&H-UO58UB7I6J/ M/X7W*+F?&^[_$L4/4$L#!!0 ( "6!<5*7BKL

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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - COVER PAGE COVER PAGE Sheet http://www.opko.com/role/COVERPAGECOVERPAGE COVER PAGE COVER PAGE Cover 1 false false All Reports Book All Reports opk-20210312.htm ex101jpmamend3-12x21.htm opk-20210312.xsd opk-20210312_cal.xml opk-20210312_def.xml opk-20210312_lab.xml opk-20210312_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "opk-20210312.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "opk-20210312_cal.xml" ] }, "definitionLink": { "local": [ "opk-20210312_def.xml" ] }, "inline": { "local": [ "opk-20210312.htm" ] }, "labelLink": { "local": [ "opk-20210312_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "opk-20210312_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "opk-20210312.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "opk", "nsuri": "http://www.opko.com/20210312", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "opk-20210312.htm", "contextRef": "ia9b92dfee05342a99d50325b0c04b390_D20210312-20210312", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - COVER PAGE COVER PAGE", "role": "http://www.opko.com/role/COVERPAGECOVERPAGE", "shortName": "COVER PAGE COVER PAGE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "opk-20210312.htm", "contextRef": "ia9b92dfee05342a99d50325b0c04b390_D20210312-20210312", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.opko.com/role/COVERPAGECOVERPAGE" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0000944809-21-000023-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000944809-21-000023-xbrl.zip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end